Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB01224_nanopub.RALeqOWhdFIBDu_R4K1fnW7o4fCUibo9bAAhskwniRbJ4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB01224 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB01224 label "DDI between Voriconazole and Quetiapine - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of quetiapine by decreasing its metabolism. Additive QTc prolongation may also occur. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of quetiapine if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB01224]" assertion.
- drugbank_resource:DB00582_DB01224 identifier "drugbank_resource:DB00582_DB01224" assertion.
- drugbank_resource:DB00582_DB01224 title "DDI between Voriconazole and Quetiapine - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of quetiapine by decreasing its metabolism. Additive QTc prolongation may also occur. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of quetiapine if voriconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB01224 assertion.
- drugbank:DB01224 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB01224 assertion.